RecruitingNCT05050617

Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism


Sponsor

WellSpan Health

Enrollment

250 participants

Start Date

Sep 9, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

This study is an observational, prospective study examining the role point-of-care echocardiography of predicting short term adverse outcomes in emergency department patients with acute pulmonary embolism. The primary objective is to assess the diagnostic performance of ultrasound-guided measures of right ventricular dilation (RVD) and strain in predicting clinical outcomes in acute PE. The secondary objective is to investigate the utility of combining ultrasound-guided measures of RVD and the pulmonary embolism severity index (PESI) score in predicting adverse outcomes in acute PE.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Age >= 18 years of age
  • ED diagnosis of acute pulmonary embolism with identification on CT imaging

Exclusion Criteria4

  • Age <18 years of age
  • Inability to provide informed consent
  • Incarceration
  • Current PE previously diagnosed prior to index ED visit

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTPoint-of-care echocardiography

Subjects will undergo point-of-care echocardiography at the time of presentation/enrollment to assess for evidence of right sided heart dilation/strain.


Locations(1)

Wellspan York Hospital

York, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05050617


Related Trials